MELPHALAN SUN 50 mg, powder and solvent for solution for injection/for infusion bottle, 15 ml
Active ingredients: Melphalan hydrochloride, Melphalan
Commercialized according to BDPMDispensing in France: Prescription only
Powder and solvent for solution for infusionbottle, 15 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MELPHALAN SUN 50 mg, poudre et solvant pour solution injectable/pour perfusion
- Pharmaceutical form
- poudre et solvant pour solution injectable pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon de poudre de 15 mL (verre) + 1 flacon de solvant de 10 mL (verre)
- Marketing authorisation holder
- SUN PHARMACEUTICAL INDUSTRIES EUROPE (PAYS BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Sept 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62252467CIP73015955CIP133400930159552Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MELPHALANpoudre | 50 mg · un flacon | FT |
| CHLORHYDRATE DE MELPHALANpoudre | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.